SAB Biotherapeutics, Inc. (NASDAQ:SABSW) Sees Large Drop in Short Interest

SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Rating) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 8,100 shares, a decrease of 64.9% from the February 28th total of 23,100 shares. Based on an average daily trading volume, of 5,400 shares, the short-interest ratio […]

Related Keywords

, Sab Biotherapeutics Inc , Nasdaq , Get Rating , Sab Biotherapeutics , Nasdaq Sabsw , Sabsw , Stocks , Options , Put , Call ,